Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.10, 2007-10, pp. : 9-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole Augmentation of Clozapine in Treatment-Resistant Schizophrenia: A Clinical Observation

By Ziegenbein Marc  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 117-124

Adis International

Access to resources Recommend Favorite

Reduction of Suicidality in Patients with Schizophrenia Receiving Clozapine

By Reinstein M.J.   Chasonov M.A.   Colombo K.D.   Jones L.E.   Sonnenberg J.G.  

Clinical Drug Investigation, Vol. 22, Iss. 5, 2002-05 ,pp. : 341-346

Adis International

Access to resources Recommend Favorite

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

By Bitter I.   Dossenbach M.R.K.   Brook S.   Feldman P.D.   Metcalfe S.   Gagiano C.A.   Furedi J.   Bartko G.   Janka Z.   Banki C.M.   Kovacs G.   Breier A.   for the Olanzapine HGCK Study Group  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 173-180

Elsevier

Access to resources Recommend Favorite

Treatment-resistant schizophrenia: clinical experience with new antipsychotics

By Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite

Ziprasidone effective in treatment-resistant schizophrenia

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite